My lab: the cancer biomarkers team

Ruth Riisnaes gives a guided tour of her lab at the Institute of Cancer Research in Sutton.

Digital pathology for the NHS

The government has announced that it is in discussion with Roche Diagnostics and partners to support the mainstream implementation of Digital Pathology services across the NHS.

NHS workforce boost planned

Health Education England (HEE) has published a long-awaited plan for how to tackle staffing issues in NHS cancer services.

NI members win award

IBMS members were among the award winners at this year’s Advancing Healthcare Awards for Northern Ireland.

Predicting breast cancer risk

Professor Gareth Evans explains his test for genetic breast cancer, which could reduce unnecessary pre-emptive mastectomies.

State-of-the-art scanner

Patients at Imperial College Healthcare NHS Trust will be the first in the world to benefit from two new state-of-the-art SPECTCT machines, which will offer the most advanced CT competences to accurately localise areas of disease.

Early cancer diagnosis study

Cancer patients are five times more likely to have surgery to remove their tumour, and less likely to have chemotherapy, if diagnosed at the earliest stage compared to the latest stage, according to new figures.

Diagnosing with holograms

Could 3D imaging developments from the US change the way that diagnostic tests are carried out?

Consent training: a biomedical scientist perspective

Senior Biomedical Scientist Olivia Geling discusses a consent training day she attended and outlines the key messages.

Histopathology reporting survey results

Brian Nation analyses the figures and draws out the trends from a survey of biomedical scientists on histopathology reporting training. 

Histopathology reporting: IBMS and RCPath statement

The IBMS and Royal College of Pathologists have come together to produce “The Role of Biomedical Scientists in Histopathology Reporting: A Joint Statement from the Royal College of Pathologists and Institute of Biomedical Science”.